Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.66 |
| ▸ | RAB9A | P51151 | 4/20 | 0.66 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.66 |
| ▸ | JAK2 | O60674 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.66 |
| ▸ | HTT | P42858 | 5/20 | 0.66 |
| ▸ | GLA | P06280 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | RNF4 | P78317 | 1/20 | 0.49 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4160577 | 0.85 | RAB9A (0.77) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL29522704 | 0.84 | NPC1 (0.57) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL8181665 | 0.84 | ALDH1A1 (0.70) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL2030599 | 0.84 | ALDH1A1 (0.70) | ALDH1A1HTTGLATSHRKMT2A | |
| SCHEMBL9492831 | 0.82 | ALDH1A1 (0.68) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL3837959 | 0.82 | ALDH1A1 (0.68) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL8759407 | 0.82 | NPC1 (0.59) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL6545547 | 0.82 | NPC1 (0.88) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL8439833 | 0.81 | NPC1 (0.46) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL18338240 | 0.81 | ALDH1A1 (0.70) | NPC1RAB9APAX8JAK2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1212056-B1 | METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES | US GOV HEALTH & HUMAN SERV (US) | 2005-12-07 | — | — | EP | claimed |
| EP-1212056-A1 | METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES | The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2002-06-12 | — | — | EP | claimed |
| US-20020002144-A1 | Methods and compositions for bisubstrate inhibitors of acetyltransferases | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2002-01-03 | — | — | US | claimed |
| WO-2001012185-A1 | METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-02-22 | — | — | WO | claimed |
| EP-0786483-B1 | Process for an activated anionic lactam polymerisation | INVENTA AG (CH) | 2000-04-19 | — | — | EP | claimed |
| US-5756647-A | LIQUID SYSTEM: CATALYST, ACTIVATOR AND SOLVENT | EMS-INVENTA AG (CH) | 1998-05-26 | — | — | US | claimed |
| EP-0786483-A2 | Process for an activated anionic lactam polymerisation | EMS-INVENTA AG (CH) | 1997-07-30 | — | — | EP | claimed |
| US-20200207989-A1 | FLUORESCENT PROBE FOR ALDH3A1 DETECTION | THE UNIVERSITY OF TOKYO (JP) | 2020-07-02 | — | — | US | disclosed |
| US-7964593-B2 | Indolone-acetamide derivatives, processes for preparing them and their uses | UCB PHARMA, S.A. (BE) | 2011-06-21 | — | — | US | disclosed |
| EP-1836163-B1 | PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN | NOVARTIS AG (CH) | 2010-09-22 | — | — | EP | disclosed |
| US-20100087427-A1 | PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN | BREITENSTEIN WERNER | 2010-04-08 | — | — | US | disclosed |
| US-20100069375-A1 | Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses | UCB PHARMA, S.A. (BE) | 2010-03-18 | — | — | US | disclosed |
| US-7645887-B2 | 2-(5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl)acetamide; epilepsy, epileptogenesis, seizure disorders and convulsion; 2-(5-chloro-2-oxo-2,3-dhydro-1H-indol-1-yl)-N-[6-(hydroxymethyl)cyclohex-3-en-1-yl]acetamide | UCB PHARMA, S.A. (BE) | 2010-01-12 | — | — | US | disclosed |
| EP-1036794-A1 | 2-ARYL-8-OXODIHYDROPURINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME, AND INTERMEDIATES THEREOF | Dainippon Pharmaceutical Co., Ltd. (JP) | 2000-09-20 | — | — | EP | disclosed |
| EP-0786482-B1 | Liquid system for the anionic lactam polymerisation | INVENTA AG (CH) | 2000-08-16 | — | — | EP | disclosed |
| US-5760164-A | STORAGE STABILITY | EMS-INVENTA AG (CH) | 1998-06-02 | — | — | US | disclosed |
| EP-0786482-A2 | Liquid system for the anionic lactam polymerisation | EMS-INVENTA AG (CH) | 1997-07-30 | — | — | EP | disclosed |
| US-4212764-A | Quaternary polyvinyl heterocyclic compositions and use as corrosion inhibitors | PETROLITE CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
| US-4099954-A | Amide phosphorothiolate herbicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-07-11 | — | — | US | disclosed |
| US-3972928-A | Regulating plant growth with quaternary phosphonium aliphatic carboxamide salts | BAYCHEM CORPORATION (US) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087427-A1 | PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN | REN, ACE, PEPD | NPC1 4017/4885RAB9A 287/4885PAX8 2728/4885 |
| US-20100069375-A1 | Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses | AANAT, TPH2, CYP1A2 | NPC1 2588/4885RAB9A 2369/4885PAX8 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.